Full-Time

IT Manager

Devops & Engineering Innovation

Posted on 11/23/2025

LabCorp

LabCorp

10,001+ employees

Global life sciences R&D services

No salary listed

Durham, NC, USA

Hybrid

Must be within a commutable distance to Labcorp offices in North Carolina.

Category
DevOps & Infrastructure (2)
,
Requirements
  • B.S. Degree in Computer Science or related field.
  • This position can be remote but must be a commutable distance to our offices in North Carolina.
  • At least 15 years of experience in DevOps Engineering (Internship experience does not apply).
  • At least 5 years of working experience in Cloud Native technologies (Amazon Web Services, Microsoft Azure, Google Cloud Platform) and IaaC.
  • At least 4 years of Unix or Linux system administration experience.
  • At least 5 years of people management experience.
  • Demonstrated experience leading and mentoring development teams using agile methodologies.
  • Excellent written and verbal communication skills, with the ability to communicate complicated analytical concepts to technical and non-technical audiences.
  • Ability to perform autonomously with minimal oversight.
  • Demonstrated ability to take initiative.
Responsibilities
  • Define and execute the enterprise DevOps roadmap, aligning with business priorities and growth goals.
  • Lead and mentor a global DevOps team to scale platform capabilities and accelerate software delivery.
  • Champion modern DevOps methodologies including CI/CD pipelines, IaC, observability, and cloud-native deployment strategies.
  • Represent the DevOps organization in executive-level discussions, providing visibility into delivery performance, innovation, and risk mitigation.
  • Evaluate and implement emerging DevOps tools and frameworks that improve productivity, resilience, and developer experience.
  • Drive experimentation and the adoption of new practices in automation, testing, and secure delivery pipelines.
  • Lead strategic initiatives for platform automation, application containerization, and cloud migration across AWS and Azure.
  • Oversee and guide the use of Terraform for managing IaaC deployments across AWS and Azure.
  • Lead DevOps implementation efforts on ECS and EKS, ensuring scalable and secure container orchestration.
  • Drive the automation of infrastructure provisioning, application deployment, and monitoring solutions using modern toolsets.
  • Collaborate closely with application teams, architects, product leaders, and security to support high-velocity, compliant delivery pipelines.
  • Act as a trusted advisor to business units and technology partners, aligning DevOps with cross-functional priorities.
  • Present roadmaps, metrics, and outcomes to C-level executives and senior stakeholders.
  • Ensure high system reliability and performance through advanced observability and proactive incident management.
  • Define and track key DevOps metrics (deployment frequency, lead time, MTTR, etc.) to improve organizational agility.
  • Promote a culture of security, compliance, and continuous improvement across engineering practices.
  • Recruit, coach, and develop a high-impact DevOps team committed to innovation and operational excellence.
  • Cultivate a culture of ownership, empowerment, and continuous learning.
  • Foster collaboration between onshore and offshore resources to maximize efficiency and coverage.
Desired Qualifications
  • Prior experience in health care fields is a plus.

Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.

Company Size

10,001+

Company Stage

IPO

Headquarters

Burlington, Vermont

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.54B, up 5.8%, raising full-year guidance to $14.73B.
  • AI Alzheimer's platform validates spring 2026, expands to oncology and cardiometabolic areas.
  • Optum.ai partnership automates lab workflows and enhances patient engagement.

What critics are saying

  • Quest Diagnostics outgrows Labcorp at 9.2% versus 5.8%, eroding diagnostics share in 6-12 months.
  • NeoGenomics seizes oncology volume with 11.1% growth, hitting Labcorp's specialty testing now.
  • Tempus commoditizes Labcorp's AI platform with superior EHR integration in 24 months.

What makes LabCorp unique

  • Labcorp's AI platform with AWS and Datavant analyzes Alzheimer's data in minutes using deidentified lab datasets.
  • Labcorp holds first FDA clearance for rapid fentanyl urine test in emergency settings.
  • Labcorp's Plasma Detect Genome MRD assesses NSCLC recurrence risk via whole-genome sequencing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Employee Stock Purchase Plan

Company News

360Dx
May 5th, 2026
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC.

Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

Resonate Group
Apr 15th, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window.

Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required

PR Newswire
Apr 14th, 2026
Labcorp launches AI-powered platform with AWS and Datavant to accelerate Alzheimer's research

Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.

360Dx
Apr 13th, 2026
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics.

Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

360Dx
Mar 20th, 2026
In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more.

In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more. NEW YORK - Laboratory Corporation of America this week said it has completed its acquisition of select assets of Crouse Health's Laboratory Alliance of Central New York's laboratory business. The two firms also have entered into a deal for Crouse Health to manage the daily operations of its inpatient lab, while Labcorp will take over operations of the lab alliance's 12 patient service centers. It said in a statement that the deal will improve access to high-quality, affordable diagnostic services in Central New York by offering patients and providers Labcorp's expanded testing menu, data, and digital tools. To read the full story... What's Popular?

INACTIVE